Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-22

Clinical Trial Update: Predicting Response to Naltrexone With Eye Tracking in Videogame Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating whether eye tracking can predict response to naltrexone in gaming disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: University of Sao Paulo | Conditions: Gaming Disorder | Phase 2 | Status: UNKNOWN